Projects
ODYSSEY - A phase III trial to evaluate the lipid lowering efficacy of a monoclonal antibody that blocks PCSKA receptors
Project Description
ODYSSEY - A phase III trial to evaluate the lipid lowering efficacy of a monoclonal antibody that blocks PCSKA receptors (Global -18924 / India -521)/ NEJM 2018-Sponsor: Duke University
Project Duration
2018 - Ongoing
Authors
-
Project Status
completed